Glenwood Medical Neuro Rehabilitation is categorized under Business Services (Unclassified) in Cambria Heights, NY .
Glenwood Medical Neuro Rehabilitation was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Business Services (Unclassified) business, which does work in the B2B market, and is classified as a Business Services (Unclassified), under code number by the NAICS.
If you are seeking more information, feel free to contact Osafradu Opam at the company’s single location by writing to 11572 Francis Louis Boulevard, Cambria Heights, New York NY 11411 or by phoning (718) 276-8666. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Glenwood Medical Neuro Rehabilitation |
| Contact Person: | Osafradu Opam |
| Address: | 11572 Francis Louis Boulevard, Cambria Heights, New York 11411 |
| Phone Number: | (718) 276-8666 |
| Annual Revenue (USD): | Unknown |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Business Services (Unclassified) |
| Share This Business: |
Glenwood Medical Neuro Rehabilitation was started in 0 to provide professional Business Services (Unclassified) under the SIC code and NAICS code . Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Osafradu Opam for inquiries that concern Glenwood Medical Neuro Rehabilitation by calling the company number (718) 276-8666, as your correspondence is most welcome. Additionally, the physical location of the single location of Glenwood Medical Neuro Rehabilitation can be found at the coordinates 40.69786,-73.74697 as well as the street address 11572 Francis Louis Boulevard in Cambria Heights, New York 11411.
For its online presence, you may visit Glenwood Medical Neuro Rehabilitation’s website at and engage with its social media outlets through on Twitter and on Facebook.